Eukaryotic translation initiation factor 4B pseudogene 6 (EIF4BP6)

Eukaryotic translation initiation factor 4B pseudogene 6 (EIF4BP6) is classified as a pseudogene, which means it is a genomic DNA sequence similar to a known gene (in this case, EIF4B), but not believed to produce a functional protein product. Pseudogenes typically arise via gene duplication or retrotransposition events followed by mutations that prevent the production of a functional protein. EIF4BP6 does not encode an active translation initiation factor and is not used as a therapeutic target or biomarker. The canonical, functional gene is EIF4B (Eukaryotic translation initiation factor 4B), which participates in translation initiation and is sometimes studied in cancer biology. Pseudogenes like EIF4BP6 have no protein-coding function and are not used in drug development or disease biology as direct targets. Occasionally, some pseudogenes may regulate their parent gene at the RNA level, but such functions are rare and EIF4BP6 is not recognized for such activity in current literature or databases. EIF4BP6 is not a receptor or therapeutic target, but rather a non-functional pseudogene related to EIF4B, with no established biological, therapeutic, or diagnostic role. The entry should be marked as incorrect or invalid for a molecular target list.

Other names

EIF4B pseudogene 6EIF4B-P6